Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary
5 clinical trials · Condition
◉ Watch Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary
| Record | Firm | Date |
|---|---|---|
| Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer (NCT02068157) | Roswell Park Cancer Institute | 2014-04-01 |
| Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT02196168) | National Cancer Institute (NCI) | 2014-03-01 |
| Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617) | National Cancer Institute (NCI) | 2011-02-10 |
| Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385) | National Cancer Institute (NCI) | 2010-11-01 |
| Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer (NCT00458978) | National Cancer Institute (NCI) | 2007-02-01 |
Track Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary automatically
Every clearance here is in the API, with alerts when new ones post.